Microglial cell dysregulation in brain aging and neurodegeneration

Frontiers in Aging Neuroscience

Volumn 7, Issue JUN, 2015, Pages

  von Bernhardi, Rommy ^a   Eugenín von Bernhardi, Laura ^a   Eugenín, Jaime ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

Author keywords

Alzheimer's disease; Glia; Mitochondria; Neurodegenerative diseases; Neuroinflammation; Oxidative stress; Reactive oxygen species; Transforming growth factor

Indexed keywords

CATHEPSIN B; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; DNA; EXCITATORY AMINO ACID TRANSPORTER 2; FRACTALKINE; GLUTAMATE RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; MITOCHONDRIAL TRANSCRIPTION FACTOR A; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; SMAD3 PROTEIN; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR TAL1; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AGING; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; BRAIN DYSFUNCTION; CELL ACTIVATION; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; DISEASE PREDISPOSITION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; GLIA CELL; HIPPOCAMPUS; INFLAMMATION; MICROGLIA; MOTOR PERFORMANCE; MOUSE; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OXIDATION REDUCTION STATE; OXIDATIVE STRESS; PATHOGENESIS; PHAGOCYTOSIS; PHENOTYPE; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; RAT; REVIEW; RISK FACTOR; TUMOR SUPPRESSOR GENE; VOXEL BASED MORPHOMETRY; YOUNG ADULT;

EID: 84936129121     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2015.00124     Document Type: Review

References (291)

1. Abrams, A.J., Farooq, A., and Wang, G. (2011). S-nitrosylation of ApoE in Alzheimer's disease. Biochemistry 50, 3405-3407.
2. Adler, A.S., Kawahara, T.L., Segal, E., and Chang, H.Y. (2008). Reversal of aging by NFkappaB blockade. Cell Cycle 7, 556-559.
3. Adler, A.S., Sinha, S., Kawahara, T.L., Zhang, J.Y., Segal, E., and Chang, H.Y. (2007). Motif module map reveals enforcement of aging by continual NF-kappaB activity. Genes Dev 21, 3244-3257.
4. Agostinho, P., Cunha, R.A., and Oliveira, C. (2010). Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease. Curr Pharm Des 16, 2766-2778.
5. Aguzzi, A., Barres, B.A., and Bennett, M.L. (2013). Microglia: scapegoat, saboteur, or something else? Science 339, 156-161.
6. Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G.M., Cooper, N.R., Eikelenboom, P., Emmerling, M., Fiebich, B.L., Finch, C.E., Frautschy, S., Griffin, W.S., Hampel, H., Hull, M., Landreth, G., Lue, L., Mrak, R., Mackenzie, I.R., Mcgeer, P.L., O'banion, M.K., Pachter, J., Pasinetti, G., Plata-Salaman, C., Rogers, J., Rydel, R., Shen, Y., Streit, W., Strohmeyer, R., Tooyoma, I., Van Muiswinkel, F.L., Veerhuis, R., Walker, D., Webster, S., Wegrzyniak, B., Wenk, G., and Wyss-Coray, T. (2000). Inflammation and Alzheimer's disease. Neurobiol Aging 21, 383-421.
7. Alarcon, R., Fuenzalida, C., Santibanez, M., and Von Bernhardi, R. (2005). Expression of scavenger receptors in glial cells. Comparing the adhesion of astrocytes and microglia from neonatal rats to surface-bound beta-amyloid. J Biol Chem 280, 30406-30415.
8. Arnaud, L., Robakis, N.K., and Figueiredo-Pereira, M.E. (2006). It may take inflammation, phosphorylation and ubiquitination to 'tangle' in Alzheimer's disease. Neurodegener Dis 3, 313-319.
9. Bachstetter, A.D., Van Eldik, L.J., Schmitt, F.A., Neltner, J.H., Ighodaro, E.T., Webster, S.J., Patel, E., Abner, E.L., Kryscio, R.J., and Nelson, P.T. (2015). Disease-related microglia heterogeneity in the hippocampus of Alzheimer's disease, dementia with Lewy bodies, and hippocampal sclerosis of aging. Acta Neuropathol Commun 3, 32.
10. Baloyannis, S.J. (2006). Mitochondrial alterations in Alzheimer's disease. J Alzheimers Dis 9, 119-126.
11. Bamberger, M.E., Harris, M.E., Mcdonald, D.R., Husemann, J., and Landreth, G.E. (2003). A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation. J Neurosci 23, 2665-2674.
12. Barger, S.W., Horster, D., Furukawa, K., Goodman, Y., Krieglstein, J., and Mattson, M.P. (1995). Tumor necrosis factors alpha and beta protect neurons against amyloid betapeptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci U S A 92, 9328-9332.
13. Baron, R., Babcock, A.A., Nemirovsky, A., Finsen, B., and Monsonego, A. (2014). Accelerated microglial pathology is associated with Abeta plaques in mouse models of Alzheimer's disease. Aging Cell 13, 584-595.
14. Barrientos, R.M., Frank, M.G., Crysdale, N.Y., Chapman, T.R., Ahrendsen, J.T., Day, H.E., Campeau, S., Watkins, L.R., Patterson, S.L., and Maier, S.F. (2011). Little exercise, big effects: reversing aging and infection-induced memory deficits, and underlying processes. J Neurosci 31, 11578-11586.
15. Barsoum, M.J., Yuan, H., Gerencser, A.A., Liot, G., Kushnareva, Y., Graber, S., Kovacs, I., Lee, W.D., Waggoner, J., Cui, J., White, A.D., Bossy, B., Martinou, J.C., Youle, R.J., Lipton, S.A., Ellisman, M.H., Perkins, G.A., and Bossy-Wetzel, E. (2006). Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons. EMBO J 25, 3900-3911.
16. Benzing, W.C., Wujek, J.R., Ward, E.K., Shaffer, D., Ashe, K.H., Younkin, S.G., and Brunden, K.R. (1999). Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice. Neurobiol Aging 20, 581-589.
17. Bhakar, A.L., Tannis, L.L., Zeindler, C., Russo, M.P., Jobin, C., Park, D.S., Macpherson, S., and Barker, P.A. (2002). Constitutive nuclear factor-kappa B activity is required for central neuron survival. J Neurosci 22, 8466-8475.
18. Bjorkqvist, M., Wild, E.J., and Tabrizi, S.J. (2009). Harnessing immune alterations in neurodegenerative diseases. Neuron 64, 21-24.
19. Blau, C.W., Cowley, T.R., O'sullivan, J., Grehan, B., Browne, T.C., Kelly, L., Birch, A., Murphy, N., Kelly, A.M., Kerskens, C.M., and Lynch, M.A. (2012). The agerelated deficit in LTP is associated with changes in perfusion and blood-brain barrier permeability. Neurobiol Aging 33, 1005 e1023-1035.
20. Blobe, G.C., Schiemann, W.P., and Lodish, H.F. (2000). Role of transforming growth factor beta in human disease. N Engl J Med 342, 1350-1358.
21. Block, M.L. (2008). NADPH oxidase as a therapeutic target in Alzheimer's disease. BMC Neurosci 9 Suppl 2, S8.
22. Block, M.L., Li, G., Qin, L., Wu, X., Pei, Z., Wang, T., Wilson, B., Yang, J., and Hong, J.S. (2006). Potent regulation of microglia-derived oxidative stress and dopaminergic neuron survival: substance P vs. dynorphin. FASEB J 20, 251-258.
23. Block, M.L., Zecca, L., and Hong, J.S. (2007). Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8, 57-69.
24. Boillee, S., Yamanaka, K., Lobsiger, C.S., Copeland, N.G., Jenkins, N.A., Kassiotis, G., Kollias, G., and Cleveland, D.W. (2006). Onset and progression in inherited ALS determined by motor neurons and microglia. Science 312, 1389-1392.
25. Bordt, E.A., and Polster, B.M. (2014). NADPH oxidase-and mitochondria-derived reactive oxygen species in proinflammatory microglial activation: a bipartisan affair? Free Radic Biol Med 76, 34-46.
26. Bossy-Wetzel, E., and Lipton, S.A. (2003). Nitric oxide signaling regulates mitochondrial number and function. Cell Death Differ 10, 757-760.
27. Butterfield, D.A. (2002). Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic Res 36, 1307-1313.
28. Butterfield, D.A., Castegna, A., Lauderback, C.M., and Drake, J. (2002). Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 23, 655-664.
29. Butterfield, D.A., and Lauderback, C.M. (2002). Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med 32, 1050-1060.
30. Bye, N., Zieba, M., Wreford, N.G., and Nichols, N.R. (2001). Resistance of the dentate gyrus to induced apoptosis during ageing is associated with increases in transforming growth factor-beta1 messenger RNA. Neuroscience 105, 853-862.
31. Cagnin, A., Brooks, D.J., Kennedy, A.M., Gunn, R.N., Myers, R., Turkheimer, F.E., Jones, T., and Banati, R.B. (2001). In-vivo measurement of activated microglia in dementia. Lancet 358, 461-467.
32. Clementi, E., Brown, G.C., Feelisch, M., and Moncada, S. (1998). Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci U S A 95, 7631-7636.
33. Combrinck, M.I., Perry, V.H., and Cunningham, C. (2002). Peripheral infection evokes exaggerated sickness behaviour in pre-clinical murine prion disease. Neuroscience 112, 7-11.
34. Conde, J.R., and Streit, W.J. (2006a). Effect of aging on the microglial response to peripheral nerve injury. Neurobiol Aging 27, 1451-1461.
35. Conde, J.R., and Streit, W.J. (2006b). Microglia in the aging brain. J Neuropathol Exp Neurol 65, 199-203.
36. Cornejo, F., and Von Bernhardi, R. (2013). Role of scavenger receptors in glia-mediated neuroinflammatory response associated with Alzheimer's disease. Mediators Inflamm 2013, 895651.
37. Cornejo, F.A., Vruwink, M., Metz, C., Ramírez, G., and Von Bernhardi, R. (2014). Role of Scavenger Receptor Class A in glial cell activation in Alzheimer's disease. Soc. Neurosci Abst 44th Annual Meeting.
38. Cunningham, C., Wilcockson, D.C., Campion, S., Lunnon, K., and Perry, V.H. (2005). Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J Neurosci 25, 9275-9284.
39. Chakrabarty, P., Jansen-West, K., Beccard, A., Ceballos-Diaz, C., Levites, Y., Verbeeck, C., Zubair, A.C., Dickson, D., Golde, T.E., and Das, P. (2010). Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J 24, 548-559.
40. Chen, L., Liu, L., Yin, J., Luo, Y., and Huang, S. (2009). Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway. Int J Biochem Cell Biol 41, 1284-1295.
41. Chen, S., Luo, D., Streit, W.J., and Harrison, J.K. (2002). TGF-beta1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia. J Neuroimmunol 133, 46-55.
42. Cho, D.H., Nakamura, T., Fang, J., Cieplak, P., Godzik, A., Gu, Z., and Lipton, S.A. (2009). S-nitrosylation of Drp1 mediates beta-amyloid-related mitochondrial fission and neuronal injury. Science 324, 102-105.
43. Cho, H.J., Kim, S.K., Jin, S.M., Hwang, E.M., Kim, Y.S., Huh, K., and Mook-Jung, I. (2007). IFN-gamma-induced BACE1 expression is mediated by activation of JAK2 and ERK1/2 signaling pathways and direct binding of STAT1 to BACE1 promoter in astrocytes. Glia 55, 253-262.
44. Cho, S.H., Chen, J.A., Sayed, F., Ward, M.E., Gao, F., Nguyen, T.A., Krabbe, G., Sohn, P.D., Lo, I., Minami, S., Devidze, N., Zhou, Y., Coppola, G., and Gan, L. (2015). SIRT1 deficiency in microglia contributes to cognitive decline in aging and neurodegeneration via epigenetic regulation of IL-1beta. J Neurosci 35, 807-818.
45. Choi, S.H., Lee, D.Y., Chung, E.S., Hong, Y.B., Kim, S.U., and Jin, B.K. (2005). Inhibition of thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo. J Neurochem 95, 1755-1765.
46. Chongthammakun, V., Sanvarinda, Y., and Chongthammakun, S. (2009). Reactive oxygen species production and MAPK activation are implicated in tetrahydrobiopterininduced SH-SY5Y cell death. Neurosci Lett 449, 178-182.
47. Damani, M.R., Zhao, L., Fontainhas, A.M., Amaral, J., Fariss, R.N., and Wong, W.T. (2011). Age-related alterations in the dynamic behavior of microglia. Aging Cell 10, 263-276.
48. Davalos, D., Grutzendler, J., Yang, G., Kim, J.V., Zuo, Y., Jung, S., Littman, D.R., Dustin, M.L., and Gan, W.B. (2005). ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8, 752-758.
49. Davis, J.N., 2nd, and Chisholm, J.C. (1999). Alois Alzheimer and the amyloid debate. Nature 400, 810.
50. Derynck, R., and Zhang, Y.E. (2003). Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425, 577-584.
51. Di Filippo, M., Sarchielli, P., Picconi, B., and Calabresi, P. (2008). Neuroinflammation and synaptic plasticity: theoretical basis for a novel, immune-centred, therapeutic approach to neurological disorders. Trends Pharmacol Sci 29, 402-412.
52. Ding, Q., Markesbery, W.R., Cecarini, V., and Keller, J.N. (2006). Decreased RNA, and increased RNA oxidation, in ribosomes from early Alzheimer's disease. Neurochem Res 31, 705-710.
53. Drachman, D.A. (2006). Aging of the brain, entropy, and Alzheimer disease. Neurology 67, 1340-1352.
54. Droge, W., and Schipper, H.M. (2007). Oxidative stress and aberrant signaling in aging and cognitive decline. Aging Cell 6, 361-370.
55. Duewell, P., Kono, H., Rayner, K.J., Sirois, C.M., Vladimer, G., Bauernfeind, F.G., Abela, G.S., Franchi, L., Nunez, G., Schnurr, M., Espevik, T., Lien, E., Fitzgerald, K.A., Rock, K.L., Moore, K.J., Wright, S.D., Hornung, V., and Latz, E. (2010). NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 1357-1361.
56. Dumont, M., Wille, E., Stack, C., Calingasan, N.Y., Beal, M.F., and Lin, M.T. (2009). Reduction of oxidative stress, amyloid deposition, and memory deficit by manganese superoxide dismutase overexpression in a transgenic mouse model of Alzheimer's disease. FASEB J 23, 2459-2466.
57. Enciu, A.M., Gherghiceanu, M., and Popescu, B.O. (2013). Triggers and effectors of oxidative stress at blood-brain barrier level: relevance for brain ageing and neurodegeneration. Oxid Med Cell Longev 2013, 297512.
58. Esposito, L., Raber, J., Kekonius, L., Yan, F., Yu, G.Q., Bien-Ly, N., Puolivali, J., Scearce-Levie, K., Masliah, E., and Mucke, L. (2006). Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J Neurosci 26, 5167-5179.
59. Flanary, B.E., Sammons, N.W., Nguyen, C., Walker, D., and Streit, W.J. (2007). Evidence that aging and amyloid promote microglial cell senescence. Rejuvenation Res 10, 61-74.
60. Flanary, B.E., and Streit, W.J. (2004). Progressive telomere shortening occurs in cultured rat microglia, but not astrocytes. Glia 45, 75-88.
61. Floden, A.M., and Combs, C.K. (2011). Microglia demonstrate age-dependent interaction with amyloid-beta fibrils. J Alzheimers Dis 25, 279-293.
62. Flores, B., and Von Bernhardi, R. (2012). Transforming growth factor beta1 modulates amyloid beta-induced glial activation through the Smad3-dependent induction of MAPK phosphatase-1. J Alzheimers Dis 32, 417-429.
63. Floyd, R.A., and Hensley, K. (2002). Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol Aging 23, 795-807.
64. Foresti, R., Bains, S.K., Pitchumony, T.S., De Castro Bras, L.E., Drago, F., Dubois-Rande, J.L., Bucolo, C., and Motterlini, R. (2013). Small molecule activators of the Nrf2-HO-1 antioxidant axis modulate heme metabolism and inflammation in BV2 microglia cells. Pharmacol Res 76, 132-148.
65. Forster, M.J., Dubey, A., Dawson, K.M., Stutts, W.A., Lal, H., and Sohal, R.S. (1996). Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain. Proc Natl Acad Sci U S A 93, 4765-4769.
66. Frank-Cannon, T.C., Alto, L.T., Mcalpine, F.E., and Tansey, M.G. (2009). Does neuroinflammation fan the flame in neurodegenerative diseases? Mol Neurodegener 4, 47.
67. Garofalo, S., D'alessandro, G., Chece, G., Brau, F., Maggi, L., Rosa, A., Porzia, A., Mainiero, F., Esposito, V., Lauro, C., Benigni, G., Bernardini, G., Santoni, A., and Limatola, C. (2015). Enriched environment reduces glioma growth through immune and non-immune mechanisms in mice. Nat Commun 6, 6623.
68. Ge, Y., Grossman, R.I., Babb, J.S., Rabin, M.L., Mannon, L.J., and Kolson, D.L. (2002). Age-related total gray matter and white matter changes in normal adult brain. Part I: volumetric MR imaging analysis. AJNR Am J Neuroradiol 23, 1327-1333.
69. Geula, C., Wu, C.K., Saroff, D., Lorenzo, A., Yuan, M., and Yankner, B.A. (1998). Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. Nat Med 4, 827-831.
70. Giasson, B.I., Ischiropoulos, H., Lee, V.M., and Trojanowski, J.Q. (2002). The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases. Free Radic Biol Med 32, 1264-1275.
71. Gill, A.J., Kovacsics, C.E., Cross, S.A., Vance, P.J., Kolson, L.L., Jordan-Sciutto, K.L., Gelman, B.B., and Kolson, D.L. (2014). Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders. J Clin Invest 124, 4459-4472.
72. Glenn, C.F., Chow, D.K., David, L., Cooke, C.A., Gami, M.S., Iser, W.B., Hanselman, K.B., Goldberg, I.G., and Wolkow, C.A. (2004). Behavioral deficits during early stages of aging in Caenorhabditis elegans result from locomotory deficits possibly linked to muscle frailty. J Gerontol A Biol Sci Med Sci 59, 1251-1260.
73. Godbout, J.P., Chen, J., Abraham, J., Richwine, A.F., Berg, B.M., Kelley, K.W., and Johnson, R.W. (2005). Exaggerated neuroinflammation and sickness behavior in aged mice following activation of the peripheral innate immune system. FASEB J 19, 1329-1331.
74. Godbout, J.P., and Johnson, R.W. (2004). Interleukin-6 in the aging brain. J Neuroimmunol 147, 141-144.
75. Godoy, B., Murgas, P., Tichauer, J., and Von Bernhardi, R. (2012). Scavenger receptor class A ligands induce secretion of IL1beta and exert a modulatory effect on the inflammatory activation of astrocytes in culture. J Neuroimmunol 251, 6-13.
76. Gordon, S. (2003). Alternative activation of macrophages. Nat Rev Immunol 3, 23-35.
77. Greig, N.H., Mattson, M.P., Perry, T., Chan, S.L., Giordano, T., Sambamurti, K., Rogers, J.T., Ovadia, H., and Lahiri, D.K. (2004). New therapeutic strategies and drug candidates for neurodegenerative diseases: p53 and TNF-alpha inhibitors, and GLP-1 receptor agonists. Ann N Y Acad Sci 1035, 290-315.
78. Griffin, W.S., and Mrak, R.E. (2002). Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J Leukoc Biol 72, 233-238.
79. Grimaldi, L.M., Casadei, V.M., Ferri, C., Veglia, F., Licastro, F., Annoni, G., Biunno, I., De Bellis, G., Sorbi, S., Mariani, C., Canal, N., Griffin, W.S., and Franceschi, M. (2000). Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann Neurol 47, 361-365.
80. Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J.S., Younkin, S., Hazrati, L., Collinge, J., Pocock, J., Lashley, T., Williams, J., Lambert, J.C., Amouyel, P., Goate, A., Rademakers, R., Morgan, K., Powell, J., St George-Hyslop, P., Singleton, A., and Hardy, J. (2013). TREM2 variants in Alzheimer's disease. N Engl J Med 368, 117-127.
81. Halle, A., Hornung, V., Petzold, G.C., Stewart, C.R., Monks, B.G., Reinheckel, T., Fitzgerald, K.A., Latz, E., Moore, K.J., and Golenbock, D.T. (2008). The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9, 857-865.
82. Halliwell, B. (2006). Oxidative stress and neurodegeneration: where are we now? J Neurochem 97, 1634-1658.
83. Hanisch, U.K., and Kettenmann, H. (2007). Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10, 1387-1394.
84. Harry, G.J. (2013). Microglia during development and aging. Pharmacol Ther 139, 313-326.
85. Harry, G.J., Lefebvre D'hellencourt, C., Bruccoleri, A., and Schmechel, D. (2000). Agedependent cytokine responses: trimethyltin hippocampal injury in wild-type, APOE knockout, and APOE4 mice. Brain Behav Immun 14, 288-304.
86. Hart, A.D., Wyttenbach, A., Perry, V.H., and Teeling, J.L. (2012). Age related changes in microglial phenotype vary between CNS regions: grey versus white matter differences. Brain Behav Immun 26, 754-765.
87. Hashioka, S., Miklossy, J., Schwab, C., Klegeris, A., and Mcgeer, P.L. (2008). Adhesion of exogenous human microglia and THP-1 cells to amyloid plaques of postmortem Alzheimer's disease brain. J Alzheimers Dis 14, 345-352.
88. Hayashi, Y., Yoshida, M., Yamato, M., Ide, T., Wu, Z., Ochi-Shindou, M., Kanki, T., Kang, D., Sunagawa, K., Tsutsui, H., and Nakanishi, H. (2008). Reverse of agedependent memory impairment and mitochondrial DNA damage in microglia by an overexpression of human mitochondrial transcription factor a in mice. J Neurosci 28, 8624-8634.
89. He, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C., Staufenbiel, M., Li, R., and Shen, Y. (2007). Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice. J Cell Biol 178, 829-841.
90. Hefendehl, J.K., Neher, J.J., Suhs, R.B., Kohsaka, S., Skodras, A., and Jucker, M. (2013). Homeostatic and injury-induced microglia behavior in the aging brain. Aging Cell, 1-10.
91. Hemmer, B., Archelos, J.J., and Hartung, H.P. (2002). New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 3, 291-301.
92. Heneka, M.T., Kummer, M.P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T.C., Gelpi, E., Halle, A., Korte, M., Latz, E., and Golenbock, D.T. (2013). NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493, 674-678.
93. Heneka, M.T., and O'banion, M.K. (2007). Inflammatory processes in Alzheimer's disease. J Neuroimmunol 184, 69-91.
94. Herrera-Molina, R., Flores, B., Orellana, J.A., and Von Bernhardi, R. (2012). Modulation of interferon-gamma-induced glial cell activation by transforming growth factor beta1: a role for STAT1 and MAPK pathways. J Neurochem 123, 113-123.
95. Herrera-Molina, R., and Von Bernhardi, R. (2005). Transforming growth factor-beta 1 produced by hippocampal cells modulates microglial reactivity in culture. Neurobiol Dis 19, 229-236.
96. Herrup, K. (2010). Reimagining Alzheimer's disease--an age-based hypothesis. J Neurosci 30, 16755-16762.
97. Hess, D.T., Matsumoto, A., Kim, S.O., Marshall, H.E., and Stamler, J.S. (2005). Protein Snitrosylation: purview and parameters. Nat Rev Mol Cell Biol 6, 150-166.
98. Heurtaux, T., Michelucci, A., Losciuto, S., Gallotti, C., Felten, P., Dorban, G., Grandbarbe, L., Morga, E., and Heuschling, P. (2010). Microglial activation depends on betaamyloid conformation: role of the formylpeptide receptor 2. J Neurochem 114, 576-586.
99. Hirsch, E.C., and Hunot, S. (2009). Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 8, 382-397.
100. Holtman, I.R., Raj, D.D., Miller, J.A., Schaafsma, W., Yin, Z., Brouwer, N., Wes, P.D., Moller, T., Orre, M., Kamphuis, W., Hol, E.M., Boddeke, E.W., and Eggen, B.J. (2015). Induction of a common microglia gene expression signature by aging and neurodegenerative conditions: a co-expression meta-analysis. Acta Neuropathol Commun 3, 31.
101. Hornung, V., Bauernfeind, F., Halle, A., Samstad, E.O., Kono, H., Rock, K.L., Fitzgerald, K.A., and Latz, E. (2008). Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9, 847-856.
102. Hu, S., Sheng, W.S., Peterson, P.K., and Chao, C.C. (1995). Cytokine modulation of murine microglial cell superoxide production. Glia 13, 45-50.
103. Husemann, J., Loike, J.D., Kodama, T., and Silverstein, S.C. (2001). Scavenger receptor class B type I (SR-BI) mediates adhesion of neonatal murine microglia to fibrillar beta-amyloid. J Neuroimmunol 114, 142-150.
104. Itagaki, S., Mcgeer, P.L., Akiyama, H., Zhu, S., and Selkoe, D. (1989). Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 24, 173-182.
105. Jellinger, K.A. (2006). Alzheimer 100--highlights in the history of Alzheimer research. J Neural Transm 113, 1603-1623.
106. Jiang, L., Chen, S.H., Chu, C.H., Wang, S.J., Oyarzabal, E., Wilson, B., Sanders, V., Xie, K., Wang, Q., and Hong, J.S. (2015). A novel role of microglial NADPH oxidase in mediating extra-synaptic function of norepinephrine in regulating brain immune homeostasis. Glia 63, 1057-1072.
107. Kang, D., Kim, S.H., and Hamasaki, N. (2007). Mitochondrial transcription factor A (TFAM): roles in maintenance of mtDNA and cellular functions. Mitochondrion 7, 39-44.
108. Kawamata, H., and Manfredi, G. (2010). Mitochondrial dysfunction and intracellular calcium dysregulation in ALS. Mech Ageing Dev 131, 517-526.
109. Ke, H.C., Huang, H.J., Liang, K.C., and Hsieh-Li, H.M. (2011). Selective improvement of cognitive function in adult and aged APP/PS1 transgenic mice by continuous nonshock treadmill exercise. Brain Res 1403, 1-11.
110. Kettenmann, H., Kirchhoff, F., and Verkhratsky, A. (2013). Microglia: new roles for the synaptic stripper. Neuron 77, 10-18.
111. Kierdorf, K., and Prinz, M. (2013). Factors regulating microglia activation. Front Cell Neurosci 7, 44.
112. Kierdorf, K., Wang, Y., and Neumann, H. (2010). Immune-mediated CNS damage. Results Probl Cell Differ 51, 173-196.
113. Kim, S.U., and De Vellis, J. (2005). Microglia in health and disease. J Neurosci Res 81, 302-313.
114. Koenigsknecht-Talboo, J., Meyer-Luehmann, M., Parsadanian, M., Garcia-Alloza, M., Finn, M.B., Hyman, B.T., Bacskai, B.J., and Holtzman, D.M. (2008). Rapid microglial response around amyloid pathology after systemic anti-Abeta antibody administration in PDAPP mice. J Neurosci 28, 14156-14164.
115. Kohman, R.A., Bhattacharya, T.K., Kilby, C., Bucko, P., and Rhodes, J.S. (2013a). Effects of minocycline on spatial learning, hippocampal neurogenesis and microglia in aged and adult mice. Behav Brain Res 242, 17-24.
116. Kohman, R.A., Bhattacharya, T.K., Wojcik, E., and Rhodes, J.S. (2013b). Exercise reduces activation of microglia isolated from hippocampus and brain of aged mice. J Neuroinflammation 10, 114.
117. Krausgruber, T., Blazek, K., Smallie, T., Alzabin, S., Lockstone, H., Sahgal, N., Hussell, T., Feldmann, M., and Udalova, I.A. (2011). IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nat Immunol 12, 231-238.
118. Kreutzberg, G.W. (1996). Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19, 312-318.
119. Kuchibhotla, K.V., Goldman, S.T., Lattarulo, C.R., Wu, H.Y., Hyman, B.T., and Bacskai, B.J. (2008). Abeta plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neuron 59, 214-225.
120. Laliberte, R.E., Perregaux, D.G., Hoth, L.R., Rosner, P.J., Jordan, C.K., Peese, K.M., Eggler, J.F., Dombroski, M.A., Geoghegan, K.F., and Gabel, C.A. (2003). Glutathione s-transferase omega 1-1 is a target of cytokine release inhibitory drugs and may be responsible for their effect on interleukin-1beta posttranslational processing. J Biol Chem 278, 16567-16578.
121. Lastres-Becker, I., Innamorato, N.G., Jaworski, T., Rabano, A., Kugler, S., Van Leuven, F., and Cuadrado, A. (2014). Fractalkine activates NRF2/NFE2L2 and heme oxygenase 1 to restrain tauopathy-induced microgliosis. Brain 137, 78-91.
122. Lauderback, C.M., Hackett, J.M., Huang, F.F., Keller, J.N., Szweda, L.I., Markesbery, W.R., and Butterfield, D.A. (2001). The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42. J Neurochem 78, 413-416.
123. Le, Y., Iribarren, P., Gong, W., Cui, Y., Zhang, X., and Wang, J.M. (2004). TGF-beta1 disrupts endotoxin signaling in microglial cells through Smad3 and MAPK pathways. J Immunol 173, 962-968.
124. Lee, J.M., Li, J., Johnson, D.A., Stein, T.D., Kraft, A.D., Calkins, M.J., Jakel, R.J., and Johnson, J.A. (2005). Nrf2, a multi-organ protector? FASEB J 19, 1061-1066.
125. Lee, J.Y., Kweon, H.S., Cho, E., Byun, H.R., Kim, D.H., Kim, Y.H., Han, P.L., and Koh, J.Y. (2007). Upregulation of tPA/plasminogen proteolytic system in the periphery of amyloid deposits in the Tg2576 mouse model of Alzheimer's disease. Neurosci Lett 423, 82-87.
126. Lee, Y.J., Han, S.B., Nam, S.Y., Oh, K.W., and Hong, J.T. (2010). Inflammation and Alzheimer's disease. Arch Pharm Res 33, 1539-1556.
127. Letiembre, M., Hao, W., Liu, Y., Walter, S., Mihaljevic, I., Rivest, S., Hartmann, T., and Fassbender, K. (2007). Innate immune receptor expression in normal brain aging. Neuroscience 146, 248-254.
128. Li, F., Calingasan, N.Y., Yu, F., Mauck, W.M., Toidze, M., Almeida, C.G., Takahashi, R.H., Carlson, G.A., Flint Beal, M., Lin, M.T., and Gouras, G.K. (2004a). Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice. J Neurochem 89, 1308-1312.
129. Li, J., Stein, T.D., and Johnson, J.A. (2004b). Genetic dissection of systemic autoimmune disease in Nrf2-deficient mice. Physiol Genomics 18, 261-272.
130. Li, L., Lu, J., Tay, S.S., Moochhala, S.M., and He, B.P. (2007). The function of microglia, either neuroprotection or neurotoxicity, is determined by the equilibrium among factors released from activated microglia in vitro. Brain Res 1159, 8-17.
131. Li, Y.J., Oliveira, S.A., Xu, P., Martin, E.R., Stenger, J.E., Scherzer, C.R., Hauser, M.A., Scott, W.K., Small, G.W., Nance, M.A., Watts, R.L., Hubble, J.P., Koller, W.C., Pahwa, R., Stern, M.B., Hiner, B.C., Jankovic, J., Goetz, C.G., Mastaglia, F., Middleton, L.T., Roses, A.D., Saunders, A.M., Schmechel, D.E., Gullans, S.R., Haines, J.L., Gilbert, J.R., Vance, J.M., Pericak-Vance, M.A., Hulette, C., and Welsh-Bohmer, K.A. (2003). Glutathione S-transferase omega-1 modifies age-atonset of Alzheimer disease and Parkinson disease. Hum Mol Genet 12, 3259-3267.
132. Lieb, K., Engels, S., and Fiebich, B.L. (2003). Inhibition of LPS-induced iNOS and NO synthesis in primary rat microglial cells. Neurochem Int 42, 131-137.
133. Lin, M.T., and Beal, M.F. (2006a). Alzheimer's APP mangles mitochondria. Nat Med 12, 1241-1243.
134. Lin, M.T., and Beal, M.F. (2006b). Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443, 787-795.
135. Lin, M.T., Simon, D.K., Ahn, C.H., Kim, L.M., and Beal, M.F. (2002). High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. Hum Mol Genet 11, 133-145.
136. Lindenberger, U., Marsiske, M., and Baltes, P.B. (2000). Memorizing while walking: increase in dual-task costs from young adulthood to old age. Psychol Aging 15, 417-436.
137. Lipsitz, L.A. (2002). Dynamics of stability: the physiologic basis of functional health and frailty. J Gerontol A Biol Sci Med Sci 57, B115-125.
138. Lipsitz, L.A., and Goldberger, A.L. (1992). Loss of 'complexity' and aging. Potential applications of fractals and chaos theory to senescence. JAMA 267, 1806-1809.
139. Liu, B., Wang, K., Gao, H.M., Mandavilli, B., Wang, J.Y., and Hong, J.S. (2001). Molecular consequences of activated microglia in the brain: overactivation induces apoptosis. J Neurochem 77, 182-189.
140. Liu, X., Wu, Z., Hayashi, Y., and Nakanishi, H. (2012). Age-dependent neuroinflammatory responses and deficits in long-term potentiation in the hippocampus during systemic inflammation. Neuroscience 216, 133-142.
141. Loncarevic-Vasiljkovic, N., Pesic, V., Todorovic, S., Popic, J., Smiljanic, K., Milanovic, D., Ruzdijic, S., and Kanazir, S. (2012). Caloric restriction suppresses microglial activation and prevents neuroapoptosis following cortical injury in rats. PLoS One 7, e37215.
142. Lopez, J.R., Lyckman, A., Oddo, S., Laferla, F.M., Querfurth, H.W., and Shtifman, A. (2008). Increased intraneuronal resting [Ca2+] in adult Alzheimer's disease mice. J Neurochem 105, 262-271.
143. Lovell, M.A., Xie, C., and Markesbery, W.R. (1998). Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology 51, 1562-1566.
144. Lovell, M.A., Xie, C., and Markesbery, W.R. (2001). Acrolein is increased in Alzheimer's disease brain and is toxic to primary hippocampal cultures. Neurobiol Aging 22, 187-194.
145. Lu, C., Zhang, D., Whiteman, M., and Armstrong, J.S. (2008). Is antioxidant potential of the mitochondrial targeted ubiquinone derivative MitoQ conserved in cells lacking mtDNA? Antioxid Redox Signal 10, 651-660.
146. Lucas, M., Zhang, X., Prasanna, V., and Mosser, D.M. (2005). ERK activation following macrophage FcgammaR ligation leads to chromatin modifications at the IL-10 locus. J Immunol 175, 469-477.
147. Lue, L.F., Kuo, Y.M., Beach, T., and Walker, D.G. (2010). Microglia activation and antiinflammatory regulation in Alzheimer's disease. Mol Neurobiol 41, 115-128.
148. Lukiw, W.J. (2004). Gene expression profiling in fetal, aged, and Alzheimer hippocampus: a continuum of stress-related signaling. Neurochem Res 29, 1287-1297.
149. Mahad, D., Ziabreva, I., Lassmann, H., and Turnbull, D. (2008). Mitochondrial defects in acute multiple sclerosis lesions. Brain 131, 1722-1735.
150. Maher, F.O., Clarke, R.M., Kelly, A., Nally, R.E., and Lynch, M.A. (2006). Interaction between interferon gamma and insulin-like growth factor-1 in hippocampus impacts on the ability of rats to sustain long-term potentiation. J Neurochem 96, 1560-1571.
151. Mandrekar-Colucci, S., Karlo, J.C., and Landreth, G.E. (2012). Mechanisms underlying the rapid peroxisome proliferator-activated receptor-gamma-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer's disease. J Neurosci 32, 10117-10128.
152. Markesbery, W.R. (1997). Oxidative stress hypothesis in Alzheimer's disease. Free Radic Biol Med 23, 134-147.
153. Martinez, F.O., Sica, A., Mantovani, A., and Locati, M. (2008). Macrophage activation and polarization. Front Biosci 13, 453-461.
154. Masters, S.L., Dunne, A., Subramanian, S.L., Hull, R.L., Tannahill, G.M., Sharp, F.A., Becker, C., Franchi, L., Yoshihara, E., Chen, Z., Mullooly, N., Mielke, L.A., Harris, J., Coll, R.C., Mills, K.H., Mok, K.H., Newsholme, P., Nunez, G., Yodoi, J., Kahn, S.E., Lavelle, E.C., and O'neill, L.A. (2010). Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1beta in type 2 diabetes. Nat Immunol 11, 897-904.
155. Mattson, M.P. (2005). NF-kappaB in the survival and plasticity of neurons. Neurochem Res 30, 883-893.
156. Mattson, M.P., and Chan, S.L. (2003). Neuronal and glial calcium signaling in Alzheimer's disease. Cell Calcium 34, 385-397.
157. Mattson, M.P., Chan, S.L., and Duan, W. (2002). Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. Physiol Rev 82, 637-672.
158. Mawuenyega, K.G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J.C., Yarasheski, K.E., and Bateman, R.J. (2010). Decreased clearance of CNS betaamyloid in Alzheimer's disease. Science 330, 1774.
159. Mccoy, M.K., Martinez, T.N., Ruhn, K.A., Szymkowski, D.E., Smith, C.G., Botterman, B.R., Tansey, K.E., and Tansey, M.G. (2006). Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's disease. J Neurosci 26, 9365-9375.
160. Mcgeer, P.L., and Mcgeer, E.G. (2001). Inflammation, autotoxicity and Alzheimer disease. Neurobiol Aging 22, 799-809.
161. Melov, S., Adlard, P.A., Morten, K., Johnson, F., Golden, T.R., Hinerfeld, D., Schilling, B., Mavros, C., Masters, C.L., Volitakis, I., Li, Q.X., Laughton, K., Hubbard, A., Cherny, R.A., Gibson, B., and Bush, A.I. (2007). Mitochondrial oxidative stress causes hyperphosphorylation of tau. PLoS One 2, e536.
162. Mittaud, P., Labourdette, G., Zingg, H., and Guenot-Di Scala, D. (2002). Neurons modulate oxytocin receptor expression in rat cultured astrocytes: involvement of TGF-beta and membrane components. Glia 37, 169-177.
163. Moreira, P.I., Zhu, X., Wang, X., Lee, H.G., Nunomura, A., Petersen, R.B., Perry, G., and Smith, M.A. (2010). Mitochondria: a therapeutic target in neurodegeneration. Biochim Biophys Acta 1802, 212-220.
164. Morgan, T.E., Wong, A.M., and Finch, C.E. (2007). Anti-inflammatory mechanisms of dietary restriction in slowing aging processes. Interdiscip Top Gerontol 35, 83-97.
165. Mosher, K.I., and Wyss-Coray, T. (2014). Microglial dysfunction in brain aging and Alzheimer's disease. Biochem Pharmacol.
166. Mosser, D.M. (2003). The many faces of macrophage activation. J Leukoc Biol 73, 209-212.
167. Mosser, D.M., and Edwards, J.P. (2008). Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8, 958-969.
168. Mount, M.P., Lira, A., Grimes, D., Smith, P.D., Faucher, S., Slack, R., Anisman, H., Hayley, S., and Park, D.S. (2007). Involvement of interferon-gamma in microglialmediated loss of dopaminergic neurons. J Neurosci 27, 3328-3337.
169. Mrak, R.E., and Griffin, W.S. (2005). Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 26, 349-354.
170. Murgas, P., Cornejo, F.A., Merino, G., and Von Bernhardi, R. (2014). SR-A regulates the inflammatory activation of astrocytes. Neurotox Res 25, 68-80.
171. Murgas, P., Godoy, B., and Von Bernhardi, R. (2012). Abeta potentiates inflammatory activation of glial cells induced by scavenger receptor ligands and inflammatory mediators in culture. Neurotox Res 22, 69-78.
172. Nakahira, K., Haspel, J.A., Rathinam, V.A., Lee, S.J., Dolinay, T., Lam, H.C., Englert, J.A., Rabinovitch, M., Cernadas, M., Kim, H.P., Fitzgerald, K.A., Ryter, S.W., and Choi, A.M. (2011). Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol 12, 222-230.
173. Nakamura, Y. (2002). Regulating factors for microglial activation. Biol Pharm Bull 25, 945-953.
174. Nakanishi, H., and Wu, Z. (2009). Microglia-aging: roles of microglial lysosome-and mitochondria-derived reactive oxygen species in brain aging. Behav Brain Res 201, 1-7.
175. Navarro, A., Sanchez Del Pino, M.J., Gomez, C., Peralta, J.L., and Boveris, A. (2002). Behavioral dysfunction, brain oxidative stress, and impaired mitochondrial electron transfer in aging mice. Am J Physiol Regul Integr Comp Physiol 282, R985-992.
176. Nayernia, Z., Jaquet, V., and Krause, K.H. (2014). New insights on NOX enzymes in the central nervous system. Antioxid Redox Signal 20, 2815-2837.
177. Neumann, H., Kotter, M.R., and Franklin, R.J. (2009). Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 132, 288-295.
178. Nguyen, M.D., Julien, J.P., and Rivest, S. (2002). Innate immunity: the missing link in neuroprotection and neurodegeneration? Nat Rev Neurosci 3, 216-227.
179. Nimmerjahn, A., Kirchhoff, F., and Helmchen, F. (2005). Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-1318.
180. Njie, E.G., Boelen, E., Stassen, F.R., Steinbusch, H.W., Borchelt, D.R., and Streit, W.J. (2010). Ex vivo cultures of microglia from young and aged rodent brain reveal agerelated changes in microglial function. Neurobiol Aging.
181. Nunomura, A., Chiba, S., Lippa, C.F., Cras, P., Kalaria, R.N., Takeda, A., Honda, K., Smith, M.A., and Perry, G. (2004). Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease. Neurobiol Dis 17, 108-113.
182. Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E.K., Jones, P.K., Ghanbari, H., Wataya, T., Shimohama, S., Chiba, S., Atwood, C.S., Petersen, R.B., and Smith, M.A. (2001). Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol 60, 759-767.
183. Oddo, S. (2008). The ubiquitin-proteasome system in Alzheimer's disease. J Cell Mol Med 12, 363-373.
184. Ouyang, X., Negishi, H., Takeda, R., Fujita, Y., Taniguchi, T., and Honda, K. (2007). Cooperation between MyD88 and TRIF pathways in TLR synergy via IRF5 activation. Biochem Biophys Res Commun 354, 1045-1051.
185. Pappolla, M.A., Chyan, Y.J., Omar, R.A., Hsiao, K., Perry, G., Smith, M.A., and Bozner, P. (1998). Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am J Pathol 152, 871-877.
186. Paresce, D.M., Chung, H., and Maxfield, F.R. (1997). Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells. J Biol Chem 272, 29390-29397.
187. Parihar, M.S., and Brewer, G.J. (2007). Simultaneous age-related depolarization of mitochondrial membrane potential and increased mitochondrial reactive oxygen species production correlate with age-related glutamate excitotoxicity in rat hippocampal neurons. J Neurosci Res 85, 1018-1032.
188. Parihar, M.S., Kunz, E.A., and Brewer, G.J. (2008). Age-related decreases in NAD(P)H and glutathione cause redox declines before ATP loss during glutamate treatment of hippocampal neurons. J Neurosci Res 86, 2339-2352.
189. Park, S.Y., Park, S.J., Park, T.G., Rajasekar, S., Lee, S.J., and Choi, Y.W. (2013). Schizandrin C exerts anti-neuroinflammatory effects by upregulating phase II detoxifying/antioxidant enzymes in microglia. Int Immunopharmacol 17, 415-426.
190. Patel, J.R., and Brewer, G.J. (2008). Age-related differences in NFkappaB translocation and Bcl-2/Bax ratio caused by TNFalpha and Abeta42 promote survival in middleage neurons and death in old neurons. Exp Neurol 213, 93-100.
191. Patten, D.A., Germain, M., Kelly, M.A., and Slack, R.S. (2010). Reactive oxygen species: stuck in the middle of neurodegeneration. J Alzheimers Dis 20 Suppl 2, S357-367.
192. Pawate, S., Shen, Q., Fan, F., and Bhat, N.R. (2004). Redox regulation of glial inflammatory response to lipopolysaccharide and interferongamma. J Neurosci Res 77, 540-551.
193. Pennypacker, K.R., Kassed, C.A., Eidizadeh, S., Saporta, S., Sanberg, P.R., and Willing, A.E. (2001). NF-kappaB p50 is increased in neurons surviving hippocampal injury. Exp Neurol 172, 307-319.
194. Perry, G., Cash, A.D., and Smith, M.A. (2002). Alzheimer Disease and Oxidative Stress. J Biomed Biotechnol 2, 120-123.
195. Perry, V.H. (2004). The influence of systemic inflammation on inflammation in the brain: implications for chronic neurodegenerative disease. Brain Behav Immun 18, 407-413.
196. Perry, V.H., Cunningham, C., and Holmes, C. (2007). Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol 7, 161-167.
197. Perry, V.H., Newman, T.A., and Cunningham, C. (2003). The impact of systemic infection on the progression of neurodegenerative disease. Nat Rev Neurosci 4, 103-112.
198. Picca, A., Fracasso, F., Pesce, V., Cantatore, P., Joseph, A.M., Leeuwenburgh, C., Gadaleta, M.N., and Lezza, A.M. (2012). Age-and calorie restriction-related changes in rat brain mitochondrial DNA and TFAM binding. Age (Dordr) 35, 1607-1620.
199. Pocock, J.M., and Kettenmann, H. (2007). Neurotransmitter receptors on microglia. Trends Neurosci 30, 527-535.
200. Polito, L., Chierchia, A., Tunesi, M., Bouybayoune, I., Kehoe, P.G., Albani, D., and Forloni, G. (2014). Environmental enrichment lessens cognitive decline in APP23 mice without affecting brain sirtuin expression. J Alzheimers Dis 42, 851-864.
201. Porta, C., Rimoldi, M., Raes, G., Brys, L., Ghezzi, P., Di Liberto, D., Dieli, F., Ghisletti, S., Natoli, G., De Baetselier, P., Mantovani, A., and Sica, A. (2009). Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor kappaB. Proc Natl Acad Sci U S A 106, 14978-14983.
202. Pratico, D., V, M.Y.L., Trojanowski, J.Q., Rokach, J., and Fitzgerald, G.A. (1998). Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo. FASEB J 12, 1777-1783.
203. Pugh, R.C., Fleshner, M., Watkins, L.R., Maier, S.F., and Rudy, J.W. (2001). The immune system and memory consolidation: a role for the cytokine IL-1beta. Neurosci Biobehav Rev 25, 29-41.
204. Qin, L., Block, M.L., Liu, Y., Bienstock, R.J., Pei, Z., Zhang, W., Wu, X., Wilson, B., Burka, T., and Hong, J.S. (2005a). Microglial NADPH oxidase is a novel target for femtomolar neuroprotection against oxidative stress. FASEB J 19, 550-557.
205. Qin, L., Li, G., Qian, X., Liu, Y., Wu, X., Liu, B., Hong, J.S., and Block, M.L. (2005b). Interactive role of the toll-like receptor 4 and reactive oxygen species in LPSinduced microglia activation. Glia 52, 78-84.
206. Qin, L., Liu, Y., Cooper, C., Liu, B., Wilson, B., and Hong, J.S. (2002). Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J Neurochem 83, 973-983.
207. Qin, L., Liu, Y., Hong, J.S., and Crews, F.T. (2013). NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration. Glia 61, 855-868.
208. Racchi, M., Uberti, D., Govoni, S., Memo, M., Lanni, C., Vasto, S., Candore, G., Caruso, C., Romeo, L., and Scapagnini, G. (2008). Alzheimer's disease: new diagnostic and therapeutic tools. Immun Ageing 5, 7.
209. Radler, M.E., Hale, M.W., and Kent, S. (2014). Calorie restriction attenuates lipopolysaccharide (LPS)-induced microglial activation in discrete regions of the hypothalamus and the subfornical organ. Brain Behav Immun 38, 13-24.
210. Radler, M.E., Wright, B.J., Walker, F.R., Hale, M.W., and Kent, S. (2015). Calorie restriction increases lipopolysaccharide-induced neuropeptide Y immunolabeling and reduces microglial cell area in the arcuate hypothalamic nucleus. Neuroscience 285, 236-247.
211. Raj, D.D., Jaarsma, D., Holtman, I.R., Olah, M., Ferreira, F.M., Schaafsma, W., Brouwer, N., Meijer, M.M., De Waard, M.C., Van Der Pluijm, I., Brandt, R., Kreft, K.L., Laman, J.D., De Haan, G., Biber, K.P., Hoeijmakers, J.H., Eggen, B.J., and Boddeke, H.W. (2014). Priming of microglia in a DNA-repair deficient model of accelerated aging. Neurobiol Aging 35, 2147-2160.
212. Ransohoff, R.M., and Perry, V.H. (2009). Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 27, 119-145.
213. Reed-Geaghan, E.G., Savage, J.C., Hise, A.G., and Landreth, G.E. (2009). CD14 and tolllike receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation. J Neurosci 29, 11982-11992.
214. Rivest, S. (2009). Regulation of innate immune responses in the brain. Nat Rev Immunol 9, 429-439.
215. Rosales-Corral, S., Reiter, R.J., Tan, D.X., Ortiz, G.G., and Lopez-Armas, G. (2010). Functional aspects of redox control during neuroinflammation. Antioxid Redox Signal 13, 193-247.
216. Ruffell, D., Mourkioti, F., Gambardella, A., Kirstetter, P., Lopez, R.G., Rosenthal, N., and Nerlov, C. (2009). A CREB-C/EBPbeta cascade induces M2 macrophage-specific gene expression and promotes muscle injury repair. Proc Natl Acad Sci U S A 106, 17475-17480.
217. Salat, D.H., Buckner, R.L., Snyder, A.Z., Greve, D.N., Desikan, R.S., Busa, E., Morris, J.C., Dale, A.M., and Fischl, B. (2004). Thinning of the cerebral cortex in aging. Cereb Cortex 14, 721-730.
218. Salat, D.H., Tuch, D.S., Hevelone, N.D., Fischl, B., Corkin, S., Rosas, H.D., and Dale, A.M. (2005). Age-related changes in prefrontal white matter measured by diffusion tensor imaging. Ann N Y Acad Sci 1064, 37-49.
219. Salminen, A., Ojala, J., Kaarniranta, K., and Kauppinen, A. (2012). Mitochondrial dysfunction and oxidative stress activate inflammasomes: impact on the aging process and age-related diseases. Cell Mol Life Sci 69, 2999-3013.
220. Santos, R.X., Correia, S.C., Wang, X., Perry, G., Smith, M.A., Moreira, P.I., and Zhu, X. (2010a). Alzheimer's disease: diverse aspects of mitochondrial malfunctioning. Int J Clin Exp Pathol 3, 570-581.
221. Santos, R.X., Correia, S.C., Wang, X., Perry, G., Smith, M.A., Moreira, P.I., and Zhu, X. (2010b). A synergistic dysfunction of mitochondrial fission/fusion dynamics and mitophagy in Alzheimer's disease. J Alzheimers Dis 20 Suppl 2, S401-412.
222. Sastre, M., Klockgether, T., and Heneka, M.T. (2006). Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms. Int J Dev Neurosci 24, 167-176.
223. Satoh, T., and Lipton, S.A. (2007). Redox regulation of neuronal survival mediated by electrophilic compounds. Trends Neurosci 30, 37-45.
224. Satoh, T., Takeuchi, O., Vandenbon, A., Yasuda, K., Tanaka, Y., Kumagai, Y., Miyake, T., Matsushita, K., Okazaki, T., Saitoh, T., Honma, K., Matsuyama, T., Yui, K., Tsujimura, T., Standley, D.M., Nakanishi, K., Nakai, K., and Akira, S. (2010). The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 11, 936-944.
225. Saud, K., Herrera-Molina, R., and Von Bernhardi, R. (2005). Pro-and anti-inflammatory cytokines regulate the ERK pathway: implication of the timing for the activation of microglial cells. Neurotox Res 8, 277-287.
226. Schipper, H.M., and Song, W. (2015). A Heme Oxygenase-1 Transducer Model of Degenerative and Developmental Brain Disorders. Int J Mol Sci 16, 5400-5419.
227. Schuitemaker, A., Van Der Doef, T.F., Boellaard, R., Van Der Flier, W.M., Yaqub, M., Windhorst, A.D., Barkhof, F., Jonker, C., Kloet, R.W., Lammertsma, A.A., Scheltens, P., and Van Berckel, B.N. (2010). Microglial activation in healthy aging. Neurobiol Aging.
228. Schwab, C., and Mcgeer, P.L. (2008). Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J Alzheimers Dis 13, 359-369.
229. Selkoe, D.J. (2002). Alzheimer's disease is a synaptic failure. Science 298, 789-791.
230. Sheng, J.G., Mrak, R.E., and Griffin, W.S. (1998). Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain. Acta Neuropathol 95, 229-234.
231. Shetty, R.A., Ikonne, U.S., Forster, M.J., and Sumien, N. (2014). Coenzyme Q10 and alpha-tocopherol reversed age-associated functional impairments in mice. Exp Gerontol 58, 208-218.
232. Shi, Q., and Gibson, G.E. (2007). Oxidative stress and transcriptional regulation in Alzheimer disease. Alzheimer Dis Assoc Disord 21, 276-291.
233. Shock, N., Greulich, R., Costa, P., Andres, R., Lakatta, E., Arenberg, D., and Tobin, J. (1984). "Normal Human Aging: The Baltimore Longitudinal Study of Aging". (Baltimore: US Department of Health and Human Services).
234. Sierra, A., Gottfried-Blackmore, A.C., Mcewen, B.S., and Bulloch, K. (2007). Microglia derived from aging mice exhibit an altered inflammatory profile. Glia 55, 412-424.
235. Simard, A.R., Soulet, D., Gowing, G., Julien, J.P., and Rivest, S. (2006). Bone marrowderived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49, 489-502.
236. Smith, R.G., Betancourt, L., and Sun, Y. (2005). Molecular endocrinology and physiology of the aging central nervous system. Endocr Rev 26, 203-250.
237. Song, Y.S., Park, H.J., Kim, S.Y., Lee, S.H., Yoo, H.S., Lee, H.S., Lee, M.K., Oh, K.W., Kang, S.K., Lee, S.E., and Hong, J.T. (2004). Protective role of Bcl-2 on betaamyloid-induced cell death of differentiated PC12 cells: reduction of NF-kappaB and p38 MAP kinase activation. Neurosci Res 49, 69-80.
238. Sowell, E.R., Peterson, B.S., Thompson, P.M., Welcome, S.E., Henkenius, A.L., and Toga, A.W. (2003). Mapping cortical change across the human life span. Nat Neurosci 6, 309-315.
239. Sriram, K., Matheson, J.M., Benkovic, S.A., Miller, D.B., Luster, M.I., and O'callaghan, J.P. (2002). Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: implications for Parkinson's disease. FASEB J 16, 1474-1476.
240. Streit, W.J. (2002). Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40, 133-139.
241. Streit, W.J. (2006). Microglial senescence: does the brain's immune system have an expiration date? Trends Neurosci 29, 506-510.
242. Streit, W.J., Braak, H., Xue, Q.S., and Bechmann, I. (2009). Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol 118, 475-485.
243. Streit, W.J., Mrak, R.E., and Griffin, W.S. (2004a). Microglia and neuroinflammation: a pathological perspective. J Neuroinflammation 1, 14.
244. Streit, W.J., Sammons, N.W., Kuhns, A.J., and Sparks, D.L. (2004b). Dystrophic microglia in the aging human brain. Glia 45, 208-212.
245. Sulciner, D.J., Irani, K., Yu, Z.X., Ferrans, V.J., Goldschmidt-Clermont, P., and Finkel, T. (1996). rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-kappaB activation. Mol Cell Biol 16, 7115-7121.
246. Swerdlow, R.H. (2007). Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? Neurobiol Aging 28, 1465-1480.
247. Swerdlow, R.H., Burns, J.M., and Khan, S.M. (2010). The Alzheimer's disease mitochondrial cascade hypothesis. J Alzheimers Dis 20 Suppl 2, S265-279.
248. Szeto, H.H. (2014). First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. Br J Pharmacol 171, 2029-2050.
249. Szeto, H.H., James, L.P., and Atkinson, A.J. (2014). Mitochondrial pharmacology: its future is now. Clin Pharmacol Ther 96, 629-633.
250. Taylor, R.C., and Dillin, A. (2011). Aging as an event of proteostasis collapse. Cold Spring Harb Perspect Biol 3.
251. Tesseur, I., and Wyss-Coray, T. (2006). A role for TGF-beta signaling in neurodegeneration: evidence from genetically engineered models. Curr Alzheimer Res 3, 505-513.
252. Tesseur, I., Zou, K., Esposito, L., Bard, F., Berber, E., Can, J.V., Lin, A.H., Crews, L., Tremblay, P., Mathews, P., Mucke, L., Masliah, E., and Wyss-Coray, T. (2006). Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology. J Clin Invest 116, 3060-3069.
253. Thanopoulou, K., Fragkouli, A., Stylianopoulou, F., and Georgopoulos, S. (2010). Scavenger receptor class B type I (SR-BI) regulates perivascular macrophages and modifies amyloid pathology in an Alzheimer mouse model. Proc Natl Acad Sci U S A 107, 20816-20821.
254. Tian, G., Kong, Q., Lai, L., Ray-Chaudhury, A., and Lin, C.L. (2010). Increased expression of cholesterol 24S-hydroxylase results in disruption of glial glutamate transporter EAAT2 association with lipid rafts: a potential role in Alzheimer's disease. J Neurochem 113, 978-989.
255. Tichauer, J., Saud, K., and Von Bernhardi, R. (2007). Modulation by astrocytes of microglial cell-mediated neuroinflammation: effect on the activation of microglial signaling pathways. Neuroimmunomodulation 14, 168-174.
256. Tichauer, J.E., Flores, B., Soler, B., Eugenin-Von Bernhardi, L., Ramirez, G., and Von Bernhardi, R. (2014). Age-dependent changes on TGFbeta1 Smad3 pathway modify the pattern of microglial cell activation. Brain Behav Immun 37, 187-196.
257. Tichauer, J.E., and Von Bernhardi, R. (2012). Transforming growth factor-beta stimulates beta amyloid uptake by microglia through Smad3-dependent mechanisms. J Neurosci Res 90, 1970-1980.
258. Toppo, S., Flohe, L., Ursini, F., Vanin, S., and Maiorino, M. (2009). Catalytic mechanisms and specificities of glutathione peroxidases: variations of a basic scheme. Biochim Biophys Acta 1790, 1486-1500.
259. Town, T., Nikolic, V., and Tan, J. (2005). The microglial "activation" continuum: from innate to adaptive responses. J Neuroinflammation 2, 24.
260. Tremblay, M.E., Zettel, M.L., Ison, J.R., Allen, P.D., and Majewska, A.K. (2012). Effects of aging and sensory loss on glial cells in mouse visual and auditory cortices. Glia 60, 541-558.
261. Trepanier, C.H., and Milgram, N.W. (2010). Neuroinflammation in Alzheimer's disease: are NSAIDs and selective COX-2 inhibitors the next line of therapy? J Alzheimers Dis 21, 1089-1099.
262. Ueberham, U., Ueberham, E., Gruschka, H., and Arendt, T. (2006). Altered subcellular location of phosphorylated Smads in Alzheimer's disease. Eur J Neurosci 24, 2327-2334.
263. Uehara, T., Nakamura, T., Yao, D., Shi, Z.Q., Gu, Z., Ma, Y., Masliah, E., Nomura, Y., and Lipton, S.A. (2006). S-nitrosylated protein-disulphide isomerase links protein misfolding to neurodegeneration. Nature 441, 513-517.
264. Uylings, H.B., and De Brabander, J.M. (2002). Neuronal changes in normal human aging and Alzheimer's disease. Brain Cogn 49, 268-276.
265. Valerio, A., Boroni, F., Benarese, M., Sarnico, I., Ghisi, V., Bresciani, L.G., Ferrario, M., Borsani, G., Spano, P., and Pizzi, M. (2006). NF-kappaB pathway: a target for preventing beta-amyloid (Abeta)-induced neuronal damage and Abeta42 production. Eur J Neurosci 23, 1711-1720.
266. Van Rossum, D., and Hanisch, U.K. (2004). Microglia. Metab Brain Dis 19, 393-411.
267. Varadarajan, S., Yatin, S., Aksenova, M., and Butterfield, D.A. (2000). Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. J Struct Biol 130, 184-208.
268. Vijg, J., and Campisi, J. (2008). Puzzles, promises and a cure for ageing. Nature 454, 1065-1071.
269. Von Bernhardi, R. (2007). Glial cell dysregulation: a new perspective on Alzheimer disease. Neurotox Res 12, 215-232.
270. Von Bernhardi, R. (2010). Immunotherapy in Alzheimer's disease: where do we stand? Where should we go? J Alzheimers Dis 19, 405-421.
271. Von Bernhardi, R., and Eugenin, J. (2004). Microglial reactivity to beta-amyloid is modulated by astrocytes and proinflammatory factors. Brain Res 1025, 186-193.
272. Von Bernhardi, R., Ramírez, G., Matile, H., and Döbeli, H. (2001). Immobilized amyloid precursor protein constructs: a tool for the in vitro screening of glial cell reactivity. Eur J Neurosci 14, 946-956.
273. Von Bernhardi, R., Tichauer, J., and Eugenin-Von Bernhardi, L. (2011). Proliferating culture of aged microglia for the study of neurodegenerative diseases. J Neurosci Methods 202, 65-69.
274. Von Bernhardi, R., Tichauer, J.E., and Eugenin, J. (2010). Aging-dependent changes of microglial cells and their relevance for neurodegenerative disorders. J Neurochem 112, 1099-1114.
275. Wang, Q., Qian, L., Chen, S.H., Chu, C.H., Wilson, B., Oyarzabal, E., Ali, S., Robinson, B., Rao, D., and Hong, J.S. (2015). Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson's disease models. Brain 138, 1247-1262.
276. Wang, T., Qin, L., Liu, B., Liu, Y., Wilson, B., Eling, T.E., Langenbach, R., Taniura, S., and Hong, J.S. (2004). Role of reactive oxygen species in LPS-induced production of prostaglandin E2 in microglia. J Neurochem 88, 939-947.
277. Wehrspaun, C.C., Haerty, W., and Ponting, C.P. (2015). Microglia recapitulate a hematopoietic master regulator network in the aging human frontal cortex. Neurobiol Aging.
278. Weiss, A., and Attisano, L. (2013). The TGFbeta superfamily signaling pathway. Wiley Interdiscip Rev Dev Biol 2, 47-63.
279. Werner, F., Jain, M.K., Feinberg, M.W., Sibinga, N.E., Pellacani, A., Wiesel, P., Chin, M.T., Topper, J.N., Perrella, M.A., and Lee, M.E. (2000). Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3. J Biol Chem 275, 36653-36658.
280. Wynn, T.A. (2003). IL-13 effector functions. Annu Rev Immunol 21, 425-456.
281. Wyss-Coray, T., Lin, C., Yan, F., Yu, G.Q., Rohde, M., Mcconlogue, L., Masliah, E., and Mucke, L. (2001). TGF-beta1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med 7, 612-618.
282. Wyss-Coray, T., and Mucke, L. (2002). Inflammation in neurodegenerative disease--a double-edged sword. Neuron 35, 419-432.
283. Yamamoto, K., Shimokawa, T., Yi, H., Isobe, K., Kojima, T., Loskutoff, D.J., and Saito, H. (2002). Aging accelerates endotoxin-induced thrombosis: increased responses of plasminogen activator inhibitor-1 and lipopolysaccharide signaling with aging. Am J Pathol 161, 1805-1814.
284. Ye, S.M., and Johnson, R.W. (1999). Increased interleukin-6 expression by microglia from brain of aged mice. J Neuroimmunol 93, 139-148.
285. Ye, S.M., and Johnson, R.W. (2001). An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice. Neuroimmunomodulation 9, 183-192.
286. Yung, R.L., and Julius, A. (2008). Epigenetics, aging, and autoimmunity. Autoimmunity 41, 329-335.
287. Zhang, J., Malik, A., Choi, H.B., Ko, R.W., Dissing-Olesen, L., and Macvicar, B.A. (2014). Microglial CR3 activation triggers long-term synaptic depression in the hippocampus via NADPH oxidase. Neuron 82, 195-207.
288. Zhang, Q., Wu, Y., Zhang, P., Sha, H., Jia, J., Hu, Y., and Zhu, J. (2012). Exercise induces mitochondrial biogenesis after brain ischemia in rats. Neuroscience 205, 10-17.
289. Zhao, W., Zhang, J., Davis, E.G., and Rebeck, G.W. (2014). Aging reduces glial uptake and promotes extracellular accumulation of Abeta from a lentiviral vector. Front Aging Neurosci 6, 210.
290. Zhou, R., Yazdi, A.S., Menu, P., and Tschopp, J. (2011). A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221-225.
291. Zhu, X., Su, B., Wang, X., Smith, M.A., and Perry, G. (2007). Causes of oxidative stress in Alzheimer disease. Cell Mol Life Sci 64, 2202-2210.